nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—hematopoietic system—stomach cancer	0.0307	0.274	CbGeAlD
Maraviroc—CCR5—lymphoid tissue—stomach cancer	0.0216	0.193	CbGeAlD
Maraviroc—CCR5—digestive system—stomach cancer	0.0214	0.19	CbGeAlD
Maraviroc—CCR5—endocrine gland—stomach cancer	0.0177	0.157	CbGeAlD
Maraviroc—CCR5—lymph node—stomach cancer	0.0122	0.109	CbGeAlD
Maraviroc—CYP3A4—hematopoietic system—stomach cancer	0.0031	0.0276	CbGeAlD
Maraviroc—CYP3A4—digestive system—stomach cancer	0.00215	0.0192	CbGeAlD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00191	0.00656	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00188	0.00649	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.00183	0.00632	CbGpPWpGaD
Maraviroc—CYP3A4—endocrine gland—stomach cancer	0.00178	0.0159	CbGeAlD
Maraviroc—CCR5—IL12-mediated signaling events—STAT3—stomach cancer	0.00173	0.00597	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.00172	0.00591	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—KISS1R—stomach cancer	0.00167	0.00576	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.00164	0.00565	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00163	0.00562	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00161	0.00556	CbGpPWpGaD
Maraviroc—CYP3A4—liver—stomach cancer	0.00161	0.0143	CbGeAlD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00157	0.00541	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.00153	0.00526	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—KISS1R—stomach cancer	0.00152	0.00523	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.00152	0.00523	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—stomach cancer	0.0015	0.00515	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.00147	0.00506	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—JUN—stomach cancer	0.00145	0.00499	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00139	0.00479	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—FYN—stomach cancer	0.00138	0.00477	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK8—stomach cancer	0.00137	0.00472	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—ERCC2—stomach cancer	0.00133	0.00458	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.00131	0.00452	CbGpPWpGaD
Maraviroc—CCR5—Disease—PGLS—stomach cancer	0.00128	0.00442	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—AGTR2—stomach cancer	0.00124	0.00428	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—F2R—stomach cancer	0.00123	0.00423	CbGpPWpGaD
Maraviroc—CCR5—Disease—RBP1—stomach cancer	0.00122	0.00421	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HRH4—stomach cancer	0.00121	0.00417	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK3—stomach cancer	0.0012	0.00413	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR1A—stomach cancer	0.0012	0.00412	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.00119	0.0041	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ANXA1—stomach cancer	0.00116	0.00398	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK1—stomach cancer	0.00114	0.00393	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ADRB1—stomach cancer	0.00112	0.00386	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.0011	0.00378	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HRH4—stomach cancer	0.0011	0.00378	CbGpPWpGaD
Maraviroc—CCR5—Disease—FBP1—stomach cancer	0.00109	0.00375	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—KISS1—stomach cancer	0.00108	0.00371	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.00106	0.00364	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—KISS1—stomach cancer	0.000979	0.00337	CbGpPWpGaD
Maraviroc—CCR5—Disease—PGAM1—stomach cancer	0.000972	0.00335	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RGS2—stomach cancer	0.000927	0.00319	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GAST—stomach cancer	0.000927	0.00319	CbGpPWpGaD
Maraviroc—CCR5—Disease—WIF1—stomach cancer	0.000927	0.00319	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—HRAS—stomach cancer	0.000915	0.00315	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ADRB2—stomach cancer	0.000907	0.00312	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KISS1R—stomach cancer	0.000898	0.00309	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GLI3—stomach cancer	0.000898	0.00309	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—stomach cancer	0.000876	0.00302	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL18—stomach cancer	0.000871	0.003	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL13—stomach cancer	0.000871	0.003	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000866	0.00298	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.000858	0.00295	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000858	0.00295	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RBP1—stomach cancer	0.000856	0.00295	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GAST—stomach cancer	0.000842	0.0029	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RGS2—stomach cancer	0.000842	0.0029	CbGpPWpGaD
Maraviroc—CCR5—Disease—RNF43—stomach cancer	0.000826	0.00285	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPS21—stomach cancer	0.000813	0.0028	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPS15—stomach cancer	0.000813	0.0028	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.00077	0.00265	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000755	0.0026	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CXCL8—stomach cancer	0.000724	0.00249	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AGTR2—stomach cancer	0.000703	0.00242	CbGpPWpGaD
Maraviroc—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000699	0.00241	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—WWOX—stomach cancer	0.000698	0.0024	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—F2R—stomach cancer	0.000695	0.00239	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR1A—stomach cancer	0.000677	0.00233	CbGpPWpGaD
Maraviroc—CCR5—Disease—ALDOB—stomach cancer	0.000673	0.00232	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL15—stomach cancer	0.00066	0.00227	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ANXA1—stomach cancer	0.000653	0.00225	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—WIF1—stomach cancer	0.000649	0.00224	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HRH4—stomach cancer	0.000649	0.00224	CbGpPWpGaD
Maraviroc—CCR5—Disease—NPM1—stomach cancer	0.000648	0.00223	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AGTR2—stomach cancer	0.000638	0.0022	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADRB1—stomach cancer	0.000633	0.00218	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—F2R—stomach cancer	0.000631	0.00217	CbGpPWpGaD
Maraviroc—CCR5—Disease—RBP4—stomach cancer	0.000626	0.00216	CbGpPWpGaD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.00062	0.00214	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPS26—stomach cancer	0.000616	0.00212	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR1A—stomach cancer	0.000614	0.00212	CbGpPWpGaD
Maraviroc—CCR5—Disease—PPIA—stomach cancer	0.000611	0.0021	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKAB1—stomach cancer	0.000599	0.00206	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ANXA1—stomach cancer	0.000593	0.00204	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RNF43—stomach cancer	0.000579	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KISS1—stomach cancer	0.000579	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000575	0.00198	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADRB1—stomach cancer	0.000575	0.00198	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPS19—stomach cancer	0.000524	0.0018	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKR1C3—stomach cancer	0.000524	0.0018	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FST—stomach cancer	0.000516	0.00178	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADRB2—stomach cancer	0.000513	0.00177	CbGpPWpGaD
Maraviroc—CCR5—Disease—ENO1—stomach cancer	0.00051	0.00176	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HBEGF—stomach cancer	0.000504	0.00174	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RGS2—stomach cancer	0.000497	0.00171	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GAST—stomach cancer	0.000497	0.00171	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGG—stomach cancer	0.000472	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADRB2—stomach cancer	0.000466	0.0016	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPS6—stomach cancer	0.000463	0.00159	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000456	0.00157	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP2R1A—stomach cancer	0.000456	0.00157	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKAA1—stomach cancer	0.000454	0.00156	CbGpPWpGaD
Maraviroc—CCR5—Disease—CD44—stomach cancer	0.000453	0.00156	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.00045	0.00155	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RBP4—stomach cancer	0.000438	0.00151	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CXCL8—stomach cancer	0.000438	0.00151	CbGpPWpGaD
Maraviroc—CCR5—Disease—HBEGF—stomach cancer	0.000426	0.00147	CbGpPWpGaD
Maraviroc—CCR5—Disease—PPP2R1A—stomach cancer	0.000385	0.00133	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HSPB1—stomach cancer	0.000377	0.0013	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AGTR2—stomach cancer	0.000377	0.0013	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—F2R—stomach cancer	0.000373	0.00128	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BMP2—stomach cancer	0.000373	0.00128	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.00037	0.00127	CbGpPWpGaD
Maraviroc—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000368	0.000615	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—AKR1C3—stomach cancer	0.000367	0.00126	CbGpPWpGaD
Maraviroc—Myalgia—Docetaxel—stomach cancer	0.000366	0.000612	CcSEcCtD
Maraviroc—Loss of consciousness—Capecitabine—stomach cancer	0.000366	0.000612	CcSEcCtD
Maraviroc—Pancytopenia—Doxorubicin—stomach cancer	0.000365	0.000612	CcSEcCtD
Maraviroc—Renal failure—Epirubicin—stomach cancer	0.000364	0.00061	CcSEcCtD
Maraviroc—Asthenia—Irinotecan—stomach cancer	0.000364	0.000609	CcSEcCtD
Maraviroc—Neuropathy peripheral—Epirubicin—stomach cancer	0.000363	0.000608	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000363	0.000608	CcSEcCtD
Maraviroc—Cough—Capecitabine—stomach cancer	0.000363	0.000608	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR1A—stomach cancer	0.000363	0.00125	CbGpPWpGaD
Maraviroc—Stomatitis—Epirubicin—stomach cancer	0.000361	0.000605	CcSEcCtD
Maraviroc—Jaundice—Epirubicin—stomach cancer	0.000361	0.000605	CcSEcCtD
Maraviroc—Conjunctivitis—Epirubicin—stomach cancer	0.00036	0.000603	CcSEcCtD
Maraviroc—Neutropenia—Doxorubicin—stomach cancer	0.00036	0.000602	CcSEcCtD
Maraviroc—Hypersensitivity—Fluorouracil—stomach cancer	0.000358	0.000599	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000358	0.000599	CcSEcCtD
Maraviroc—CCR5—Disease—SMAD4—stomach cancer	0.000357	0.00123	CbGpPWpGaD
Maraviroc—Myalgia—Capecitabine—stomach cancer	0.000354	0.000593	CcSEcCtD
Maraviroc—Pharyngitis—Methotrexate—stomach cancer	0.000353	0.000591	CcSEcCtD
Maraviroc—Anxiety—Capecitabine—stomach cancer	0.000353	0.000591	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000352	0.000589	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PRKCB—stomach cancer	0.000351	0.00121	CbGpPWpGaD
Maraviroc—Urinary tract disorder—Methotrexate—stomach cancer	0.000351	0.000588	CcSEcCtD
Maraviroc—Hepatobiliary disease—Epirubicin—stomach cancer	0.000351	0.000587	CcSEcCtD
Maraviroc—Oedema—Docetaxel—stomach cancer	0.000351	0.000587	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ANXA1—stomach cancer	0.00035	0.00121	CbGpPWpGaD
Maraviroc—Discomfort—Capecitabine—stomach cancer	0.00035	0.000586	CcSEcCtD
Maraviroc—Urethral disorder—Methotrexate—stomach cancer	0.000349	0.000584	CcSEcCtD
Maraviroc—Infection—Docetaxel—stomach cancer	0.000348	0.000583	CcSEcCtD
Maraviroc—Sinusitis—Epirubicin—stomach cancer	0.000348	0.000582	CcSEcCtD
Maraviroc—Diarrhoea—Irinotecan—stomach cancer	0.000347	0.000581	CcSEcCtD
Maraviroc—Agranulocytosis—Epirubicin—stomach cancer	0.000346	0.000579	CcSEcCtD
Maraviroc—Pneumonia—Doxorubicin—stomach cancer	0.000345	0.000578	CcSEcCtD
Maraviroc—Shock—Docetaxel—stomach cancer	0.000345	0.000577	CcSEcCtD
Maraviroc—Nervous system disorder—Docetaxel—stomach cancer	0.000344	0.000576	CcSEcCtD
Maraviroc—Pruritus—Fluorouracil—stomach cancer	0.000344	0.000575	CcSEcCtD
Maraviroc—Infestation NOS—Doxorubicin—stomach cancer	0.000343	0.000574	CcSEcCtD
Maraviroc—Infestation—Doxorubicin—stomach cancer	0.000343	0.000574	CcSEcCtD
Maraviroc—Skin disorder—Docetaxel—stomach cancer	0.000341	0.00057	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00034	0.000569	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADRB1—stomach cancer	0.000339	0.00117	CbGpPWpGaD
Maraviroc—Oedema—Capecitabine—stomach cancer	0.000339	0.000568	CcSEcCtD
Maraviroc—CCR5—Disease—FYN—stomach cancer	0.000339	0.00117	CbGpPWpGaD
Maraviroc—Renal failure—Doxorubicin—stomach cancer	0.000337	0.000564	CcSEcCtD
Maraviroc—Infection—Capecitabine—stomach cancer	0.000337	0.000564	CcSEcCtD
Maraviroc—Erythema multiforme—Methotrexate—stomach cancer	0.000336	0.000563	CcSEcCtD
Maraviroc—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000336	0.000563	CcSEcCtD
Maraviroc—Dizziness—Irinotecan—stomach cancer	0.000335	0.000561	CcSEcCtD
Maraviroc—Jaundice—Doxorubicin—stomach cancer	0.000334	0.00056	CcSEcCtD
Maraviroc—Stomatitis—Doxorubicin—stomach cancer	0.000334	0.00056	CcSEcCtD
Maraviroc—Anorexia—Docetaxel—stomach cancer	0.000334	0.000559	CcSEcCtD
Maraviroc—Shock—Capecitabine—stomach cancer	0.000334	0.000559	CcSEcCtD
Maraviroc—Rhinitis—Epirubicin—stomach cancer	0.000334	0.000559	CcSEcCtD
Maraviroc—Conjunctivitis—Doxorubicin—stomach cancer	0.000333	0.000558	CcSEcCtD
Maraviroc—Nervous system disorder—Capecitabine—stomach cancer	0.000333	0.000557	CcSEcCtD
Maraviroc—Eye disorder—Methotrexate—stomach cancer	0.000332	0.000556	CcSEcCtD
Maraviroc—Diarrhoea—Fluorouracil—stomach cancer	0.000332	0.000556	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000332	0.00114	CbGpPWpGaD
Maraviroc—Pharyngitis—Epirubicin—stomach cancer	0.00033	0.000553	CcSEcCtD
Maraviroc—Cardiac disorder—Methotrexate—stomach cancer	0.00033	0.000553	CcSEcCtD
Maraviroc—Skin disorder—Capecitabine—stomach cancer	0.00033	0.000552	CcSEcCtD
Maraviroc—Urinary tract disorder—Epirubicin—stomach cancer	0.000329	0.00055	CcSEcCtD
Maraviroc—Connective tissue disorder—Epirubicin—stomach cancer	0.000327	0.000548	CcSEcCtD
Maraviroc—Urethral disorder—Epirubicin—stomach cancer	0.000326	0.000546	CcSEcCtD
Maraviroc—CCR5—Disease—ERCC2—stomach cancer	0.000326	0.00112	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000324	0.000543	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—RPS6—stomach cancer	0.000324	0.00112	CbGpPWpGaD
Maraviroc—Anorexia—Capecitabine—stomach cancer	0.000324	0.000542	CcSEcCtD
Maraviroc—Angiopathy—Methotrexate—stomach cancer	0.000323	0.00054	CcSEcCtD
Maraviroc—Vomiting—Irinotecan—stomach cancer	0.000322	0.00054	CcSEcCtD
Maraviroc—Sinusitis—Doxorubicin—stomach cancer	0.000322	0.000539	CcSEcCtD
Maraviroc—Dizziness—Fluorouracil—stomach cancer	0.000321	0.000538	CcSEcCtD
Maraviroc—Mediastinal disorder—Methotrexate—stomach cancer	0.000321	0.000537	CcSEcCtD
Maraviroc—Agranulocytosis—Doxorubicin—stomach cancer	0.00032	0.000536	CcSEcCtD
Maraviroc—Rash—Irinotecan—stomach cancer	0.00032	0.000535	CcSEcCtD
Maraviroc—Dermatitis—Irinotecan—stomach cancer	0.000319	0.000535	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000319	0.000535	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PRKCB—stomach cancer	0.000319	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Disease—FGFR2—stomach cancer	0.000319	0.0011	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6ST—stomach cancer	0.000318	0.00109	CbGpPWpGaD
Maraviroc—Headache—Irinotecan—stomach cancer	0.000318	0.000532	CcSEcCtD
Maraviroc—Insomnia—Docetaxel—stomach cancer	0.000317	0.000531	CcSEcCtD
Maraviroc—Paraesthesia—Docetaxel—stomach cancer	0.000315	0.000527	CcSEcCtD
Maraviroc—Erythema multiforme—Epirubicin—stomach cancer	0.000315	0.000527	CcSEcCtD
Maraviroc—Alopecia—Methotrexate—stomach cancer	0.000314	0.000526	CcSEcCtD
Maraviroc—Mental disorder—Methotrexate—stomach cancer	0.000312	0.000522	CcSEcCtD
Maraviroc—Eye disorder—Epirubicin—stomach cancer	0.000311	0.000521	CcSEcCtD
Maraviroc—Erythema—Methotrexate—stomach cancer	0.00031	0.000518	CcSEcCtD
Maraviroc—Malnutrition—Methotrexate—stomach cancer	0.00031	0.000518	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000309	0.000518	CcSEcCtD
Maraviroc—Cardiac disorder—Epirubicin—stomach cancer	0.000309	0.000517	CcSEcCtD
Maraviroc—Vomiting—Fluorouracil—stomach cancer	0.000309	0.000517	CcSEcCtD
Maraviroc—Rhinitis—Doxorubicin—stomach cancer	0.000309	0.000517	CcSEcCtD
Maraviroc—Insomnia—Capecitabine—stomach cancer	0.000307	0.000514	CcSEcCtD
Maraviroc—CCR5—Disease—MTHFR—stomach cancer	0.000307	0.00106	CbGpPWpGaD
Maraviroc—Rash—Fluorouracil—stomach cancer	0.000306	0.000513	CcSEcCtD
Maraviroc—Dermatitis—Fluorouracil—stomach cancer	0.000306	0.000512	CcSEcCtD
Maraviroc—Pharyngitis—Doxorubicin—stomach cancer	0.000306	0.000512	CcSEcCtD
Maraviroc—Paraesthesia—Capecitabine—stomach cancer	0.000305	0.00051	CcSEcCtD
Maraviroc—Decreased appetite—Docetaxel—stomach cancer	0.000305	0.00051	CcSEcCtD
Maraviroc—Headache—Fluorouracil—stomach cancer	0.000304	0.000509	CcSEcCtD
Maraviroc—Urinary tract disorder—Doxorubicin—stomach cancer	0.000304	0.000509	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000303	0.000507	CcSEcCtD
Maraviroc—Connective tissue disorder—Doxorubicin—stomach cancer	0.000303	0.000507	CcSEcCtD
Maraviroc—Fatigue—Docetaxel—stomach cancer	0.000302	0.000506	CcSEcCtD
Maraviroc—Angiopathy—Epirubicin—stomach cancer	0.000302	0.000505	CcSEcCtD
Maraviroc—Urethral disorder—Doxorubicin—stomach cancer	0.000302	0.000505	CcSEcCtD
Maraviroc—Nausea—Irinotecan—stomach cancer	0.000301	0.000504	CcSEcCtD
Maraviroc—Mediastinal disorder—Epirubicin—stomach cancer	0.0003	0.000502	CcSEcCtD
Maraviroc—Pain—Docetaxel—stomach cancer	0.0003	0.000502	CcSEcCtD
Maraviroc—Constipation—Docetaxel—stomach cancer	0.0003	0.000502	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HBEGF—stomach cancer	0.000298	0.00103	CbGpPWpGaD
Maraviroc—Decreased appetite—Capecitabine—stomach cancer	0.000295	0.000494	CcSEcCtD
Maraviroc—Alopecia—Epirubicin—stomach cancer	0.000294	0.000492	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000293	0.000491	CcSEcCtD
Maraviroc—Fatigue—Capecitabine—stomach cancer	0.000293	0.00049	CcSEcCtD
Maraviroc—CCR5—Disease—IRS2—stomach cancer	0.000292	0.001	CbGpPWpGaD
Maraviroc—Mental disorder—Epirubicin—stomach cancer	0.000292	0.000488	CcSEcCtD
Maraviroc—Erythema multiforme—Doxorubicin—stomach cancer	0.000291	0.000487	CcSEcCtD
Maraviroc—Pain—Capecitabine—stomach cancer	0.00029	0.000486	CcSEcCtD
Maraviroc—Constipation—Capecitabine—stomach cancer	0.00029	0.000486	CcSEcCtD
Maraviroc—Erythema—Epirubicin—stomach cancer	0.00029	0.000485	CcSEcCtD
Maraviroc—Malnutrition—Epirubicin—stomach cancer	0.00029	0.000485	CcSEcCtD
Maraviroc—Nausea—Fluorouracil—stomach cancer	0.000289	0.000483	CcSEcCtD
Maraviroc—Eye disorder—Doxorubicin—stomach cancer	0.000288	0.000482	CcSEcCtD
Maraviroc—Gastrointestinal pain—Docetaxel—stomach cancer	0.000287	0.00048	CcSEcCtD
Maraviroc—Anaemia—Methotrexate—stomach cancer	0.000286	0.000479	CcSEcCtD
Maraviroc—Cardiac disorder—Doxorubicin—stomach cancer	0.000286	0.000478	CcSEcCtD
Maraviroc—Flatulence—Epirubicin—stomach cancer	0.000286	0.000478	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6R—stomach cancer	0.000284	0.000977	CbGpPWpGaD
Maraviroc—CCR5—Disease—CAV1—stomach cancer	0.000283	0.000974	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOA1—stomach cancer	0.000282	0.000972	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RHOA—stomach cancer	0.000282	0.000971	CbGpPWpGaD
Maraviroc—Angiopathy—Doxorubicin—stomach cancer	0.000279	0.000468	CcSEcCtD
Maraviroc—Gastrointestinal pain—Capecitabine—stomach cancer	0.000278	0.000465	CcSEcCtD
Maraviroc—Mediastinal disorder—Doxorubicin—stomach cancer	0.000278	0.000465	CcSEcCtD
Maraviroc—Abdominal pain—Docetaxel—stomach cancer	0.000277	0.000464	CcSEcCtD
Maraviroc—Body temperature increased—Docetaxel—stomach cancer	0.000277	0.000464	CcSEcCtD
Maraviroc—Leukopenia—Methotrexate—stomach cancer	0.000277	0.000464	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADRB2—stomach cancer	0.000275	0.000947	CbGpPWpGaD
Maraviroc—Alopecia—Doxorubicin—stomach cancer	0.000272	0.000456	CcSEcCtD
Maraviroc—Cough—Methotrexate—stomach cancer	0.00027	0.000452	CcSEcCtD
Maraviroc—Mental disorder—Doxorubicin—stomach cancer	0.00027	0.000452	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PPP2R1A—stomach cancer	0.00027	0.000928	CbGpPWpGaD
Maraviroc—Body temperature increased—Capecitabine—stomach cancer	0.000268	0.000449	CcSEcCtD
Maraviroc—Abdominal pain—Capecitabine—stomach cancer	0.000268	0.000449	CcSEcCtD
Maraviroc—Convulsion—Methotrexate—stomach cancer	0.000268	0.000449	CcSEcCtD
Maraviroc—CCR5—Disease—IL6ST—stomach cancer	0.000268	0.000923	CbGpPWpGaD
Maraviroc—Erythema—Doxorubicin—stomach cancer	0.000268	0.000449	CcSEcCtD
Maraviroc—Malnutrition—Doxorubicin—stomach cancer	0.000268	0.000449	CcSEcCtD
Maraviroc—Anaemia—Epirubicin—stomach cancer	0.000268	0.000448	CcSEcCtD
Maraviroc—Flatulence—Doxorubicin—stomach cancer	0.000264	0.000442	CcSEcCtD
Maraviroc—Myalgia—Methotrexate—stomach cancer	0.000264	0.000441	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000262	0.000438	CcSEcCtD
Maraviroc—Discomfort—Methotrexate—stomach cancer	0.00026	0.000436	CcSEcCtD
Maraviroc—Syncope—Epirubicin—stomach cancer	0.00026	0.000435	CcSEcCtD
Maraviroc—Leukopenia—Epirubicin—stomach cancer	0.000259	0.000434	CcSEcCtD
Maraviroc—Hypersensitivity—Docetaxel—stomach cancer	0.000258	0.000432	CcSEcCtD
Maraviroc—CCR5—Disease—APC—stomach cancer	0.000258	0.000887	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RHOA—stomach cancer	0.000256	0.000882	CbGpPWpGaD
Maraviroc—Loss of consciousness—Epirubicin—stomach cancer	0.000255	0.000426	CcSEcCtD
Maraviroc—Cough—Epirubicin—stomach cancer	0.000253	0.000423	CcSEcCtD
Maraviroc—Asthenia—Docetaxel—stomach cancer	0.000252	0.000421	CcSEcCtD
Maraviroc—Convulsion—Epirubicin—stomach cancer	0.000251	0.00042	CcSEcCtD
Maraviroc—Infection—Methotrexate—stomach cancer	0.000251	0.00042	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SMAD4—stomach cancer	0.00025	0.000862	CbGpPWpGaD
Maraviroc—Hypersensitivity—Capecitabine—stomach cancer	0.00025	0.000419	CcSEcCtD
Maraviroc—Pruritus—Docetaxel—stomach cancer	0.000248	0.000415	CcSEcCtD
Maraviroc—Nervous system disorder—Methotrexate—stomach cancer	0.000248	0.000415	CcSEcCtD
Maraviroc—Anaemia—Doxorubicin—stomach cancer	0.000248	0.000415	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—stomach cancer	0.000248	0.000853	CbGpPWpGaD
Maraviroc—Myalgia—Epirubicin—stomach cancer	0.000247	0.000413	CcSEcCtD
Maraviroc—Anxiety—Epirubicin—stomach cancer	0.000246	0.000411	CcSEcCtD
Maraviroc—Skin disorder—Methotrexate—stomach cancer	0.000245	0.000411	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000245	0.00041	CcSEcCtD
Maraviroc—Discomfort—Epirubicin—stomach cancer	0.000244	0.000408	CcSEcCtD
Maraviroc—Asthenia—Capecitabine—stomach cancer	0.000244	0.000408	CcSEcCtD
Maraviroc—Anorexia—Methotrexate—stomach cancer	0.000241	0.000403	CcSEcCtD
Maraviroc—Syncope—Doxorubicin—stomach cancer	0.00024	0.000402	CcSEcCtD
Maraviroc—Pruritus—Capecitabine—stomach cancer	0.00024	0.000402	CcSEcCtD
Maraviroc—Leukopenia—Doxorubicin—stomach cancer	0.00024	0.000402	CcSEcCtD
Maraviroc—Diarrhoea—Docetaxel—stomach cancer	0.00024	0.000402	CcSEcCtD
Maraviroc—CCR5—Disease—IL6R—stomach cancer	0.000239	0.000824	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FYN—stomach cancer	0.000238	0.000818	CbGpPWpGaD
Maraviroc—Oedema—Epirubicin—stomach cancer	0.000236	0.000396	CcSEcCtD
Maraviroc—Loss of consciousness—Doxorubicin—stomach cancer	0.000236	0.000394	CcSEcCtD
Maraviroc—Infection—Epirubicin—stomach cancer	0.000235	0.000393	CcSEcCtD
Maraviroc—Cough—Doxorubicin—stomach cancer	0.000234	0.000392	CcSEcCtD
Maraviroc—Shock—Epirubicin—stomach cancer	0.000233	0.000389	CcSEcCtD
Maraviroc—Convulsion—Doxorubicin—stomach cancer	0.000232	0.000389	CcSEcCtD
Maraviroc—Diarrhoea—Capecitabine—stomach cancer	0.000232	0.000389	CcSEcCtD
Maraviroc—Nervous system disorder—Epirubicin—stomach cancer	0.000232	0.000388	CcSEcCtD
Maraviroc—Dizziness—Docetaxel—stomach cancer	0.000232	0.000388	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00023	0.000385	CcSEcCtD
Maraviroc—Skin disorder—Epirubicin—stomach cancer	0.00023	0.000384	CcSEcCtD
Maraviroc—Insomnia—Methotrexate—stomach cancer	0.000229	0.000383	CcSEcCtD
Maraviroc—Myalgia—Doxorubicin—stomach cancer	0.000228	0.000382	CcSEcCtD
Maraviroc—Anxiety—Doxorubicin—stomach cancer	0.000227	0.000381	CcSEcCtD
Maraviroc—Paraesthesia—Methotrexate—stomach cancer	0.000227	0.00038	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000227	0.000379	CcSEcCtD
Maraviroc—Discomfort—Doxorubicin—stomach cancer	0.000226	0.000377	CcSEcCtD
Maraviroc—Anorexia—Epirubicin—stomach cancer	0.000225	0.000377	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—stomach cancer	0.000225	0.000774	CbGpPWpGaD
Maraviroc—Dizziness—Capecitabine—stomach cancer	0.000224	0.000376	CcSEcCtD
Maraviroc—CCR5—Disease—SERPINE1—stomach cancer	0.000224	0.000771	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGFR2—stomach cancer	0.000223	0.000768	CbGpPWpGaD
Maraviroc—Vomiting—Docetaxel—stomach cancer	0.000223	0.000373	CcSEcCtD
Maraviroc—Rash—Docetaxel—stomach cancer	0.000221	0.00037	CcSEcCtD
Maraviroc—Dermatitis—Docetaxel—stomach cancer	0.000221	0.00037	CcSEcCtD
Maraviroc—Decreased appetite—Methotrexate—stomach cancer	0.00022	0.000368	CcSEcCtD
Maraviroc—Headache—Docetaxel—stomach cancer	0.00022	0.000368	CcSEcCtD
Maraviroc—Oedema—Doxorubicin—stomach cancer	0.000219	0.000366	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000218	0.000365	CcSEcCtD
Maraviroc—Fatigue—Methotrexate—stomach cancer	0.000218	0.000365	CcSEcCtD
Maraviroc—Infection—Doxorubicin—stomach cancer	0.000217	0.000364	CcSEcCtD
Maraviroc—Pain—Methotrexate—stomach cancer	0.000216	0.000362	CcSEcCtD
Maraviroc—CCR5—Disease—RHOA—stomach cancer	0.000216	0.000744	CbGpPWpGaD
Maraviroc—Vomiting—Capecitabine—stomach cancer	0.000216	0.000361	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000215	0.000361	CcSEcCtD
Maraviroc—Shock—Doxorubicin—stomach cancer	0.000215	0.00036	CcSEcCtD
Maraviroc—Nervous system disorder—Doxorubicin—stomach cancer	0.000215	0.000359	CcSEcCtD
Maraviroc—Rash—Capecitabine—stomach cancer	0.000214	0.000358	CcSEcCtD
Maraviroc—Insomnia—Epirubicin—stomach cancer	0.000214	0.000358	CcSEcCtD
Maraviroc—CCR5—Disease—NOS3—stomach cancer	0.000214	0.000736	CbGpPWpGaD
Maraviroc—Dermatitis—Capecitabine—stomach cancer	0.000214	0.000358	CcSEcCtD
Maraviroc—Headache—Capecitabine—stomach cancer	0.000213	0.000356	CcSEcCtD
Maraviroc—Skin disorder—Doxorubicin—stomach cancer	0.000213	0.000356	CcSEcCtD
Maraviroc—Paraesthesia—Epirubicin—stomach cancer	0.000212	0.000355	CcSEcCtD
Maraviroc—Anorexia—Doxorubicin—stomach cancer	0.000209	0.000349	CcSEcCtD
Maraviroc—Nausea—Docetaxel—stomach cancer	0.000208	0.000349	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methotrexate—stomach cancer	0.000207	0.000346	CcSEcCtD
Maraviroc—Decreased appetite—Epirubicin—stomach cancer	0.000206	0.000344	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IRS2—stomach cancer	0.000204	0.000703	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000204	0.000342	CcSEcCtD
Maraviroc—Fatigue—Epirubicin—stomach cancer	0.000204	0.000341	CcSEcCtD
Maraviroc—Pain—Epirubicin—stomach cancer	0.000202	0.000338	CcSEcCtD
Maraviroc—Constipation—Epirubicin—stomach cancer	0.000202	0.000338	CcSEcCtD
Maraviroc—Nausea—Capecitabine—stomach cancer	0.000202	0.000337	CcSEcCtD
Maraviroc—CCR5—Disease—ERBB2—stomach cancer	0.0002	0.000689	CbGpPWpGaD
Maraviroc—Abdominal pain—Methotrexate—stomach cancer	0.0002	0.000334	CcSEcCtD
Maraviroc—Body temperature increased—Methotrexate—stomach cancer	0.0002	0.000334	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000199	0.000334	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000199	0.000685	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CAV1—stomach cancer	0.000198	0.000682	CbGpPWpGaD
Maraviroc—Insomnia—Doxorubicin—stomach cancer	0.000198	0.000331	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APOA1—stomach cancer	0.000198	0.00068	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000197	0.000677	CbGpPWpGaD
Maraviroc—Paraesthesia—Doxorubicin—stomach cancer	0.000196	0.000329	CcSEcCtD
Maraviroc—CCR5—Disease—PTGS2—stomach cancer	0.000196	0.000674	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Epirubicin—stomach cancer	0.000193	0.000324	CcSEcCtD
Maraviroc—Decreased appetite—Doxorubicin—stomach cancer	0.00019	0.000318	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000189	0.000316	CcSEcCtD
Maraviroc—Fatigue—Doxorubicin—stomach cancer	0.000189	0.000316	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000189	0.000649	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCB—stomach cancer	0.000189	0.000649	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6ST—stomach cancer	0.000188	0.000647	CbGpPWpGaD
Maraviroc—Constipation—Doxorubicin—stomach cancer	0.000187	0.000313	CcSEcCtD
Maraviroc—Pain—Doxorubicin—stomach cancer	0.000187	0.000313	CcSEcCtD
Maraviroc—Body temperature increased—Epirubicin—stomach cancer	0.000187	0.000313	CcSEcCtD
Maraviroc—Abdominal pain—Epirubicin—stomach cancer	0.000187	0.000313	CcSEcCtD
Maraviroc—Hypersensitivity—Methotrexate—stomach cancer	0.000186	0.000312	CcSEcCtD
Maraviroc—CCR5—Disease—CDKN1B—stomach cancer	0.000185	0.000638	CbGpPWpGaD
Maraviroc—Asthenia—Methotrexate—stomach cancer	0.000181	0.000303	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APC—stomach cancer	0.00018	0.000621	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000179	0.000299	CcSEcCtD
Maraviroc—Pruritus—Methotrexate—stomach cancer	0.000179	0.000299	CcSEcCtD
Maraviroc—Hypersensitivity—Epirubicin—stomach cancer	0.000174	0.000292	CcSEcCtD
Maraviroc—Abdominal pain—Doxorubicin—stomach cancer	0.000173	0.00029	CcSEcCtD
Maraviroc—Body temperature increased—Doxorubicin—stomach cancer	0.000173	0.00029	CcSEcCtD
Maraviroc—Diarrhoea—Methotrexate—stomach cancer	0.000173	0.000289	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—MAPK3—stomach cancer	0.000173	0.000595	CbGpPWpGaD
Maraviroc—CCR5—Disease—CDKN1A—stomach cancer	0.000171	0.000589	CbGpPWpGaD
Maraviroc—Asthenia—Epirubicin—stomach cancer	0.00017	0.000284	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IL6R—stomach cancer	0.000168	0.000577	CbGpPWpGaD
Maraviroc—Pruritus—Epirubicin—stomach cancer	0.000167	0.00028	CcSEcCtD
Maraviroc—Dizziness—Methotrexate—stomach cancer	0.000167	0.00028	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—MAPK1—stomach cancer	0.000164	0.000566	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—EGFR—stomach cancer	0.000164	0.000566	CbGpPWpGaD
Maraviroc—Diarrhoea—Epirubicin—stomach cancer	0.000162	0.000271	CcSEcCtD
Maraviroc—Hypersensitivity—Doxorubicin—stomach cancer	0.000161	0.00027	CcSEcCtD
Maraviroc—Vomiting—Methotrexate—stomach cancer	0.000161	0.000269	CcSEcCtD
Maraviroc—Rash—Methotrexate—stomach cancer	0.000159	0.000267	CcSEcCtD
Maraviroc—Dermatitis—Methotrexate—stomach cancer	0.000159	0.000266	CcSEcCtD
Maraviroc—Headache—Methotrexate—stomach cancer	0.000158	0.000265	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CA—stomach cancer	0.000157	0.000541	CbGpPWpGaD
Maraviroc—Asthenia—Doxorubicin—stomach cancer	0.000157	0.000263	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SERPINE1—stomach cancer	0.000157	0.00054	CbGpPWpGaD
Maraviroc—Dizziness—Epirubicin—stomach cancer	0.000156	0.000262	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—KRAS—stomach cancer	0.000155	0.000535	CbGpPWpGaD
Maraviroc—Pruritus—Doxorubicin—stomach cancer	0.000155	0.000259	CcSEcCtD
Maraviroc—CCR5—Disease—STAT3—stomach cancer	0.000153	0.000525	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RHOA—stomach cancer	0.000151	0.000521	CbGpPWpGaD
Maraviroc—Vomiting—Epirubicin—stomach cancer	0.00015	0.000252	CcSEcCtD
Maraviroc—Nausea—Methotrexate—stomach cancer	0.00015	0.000251	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NOS3—stomach cancer	0.00015	0.000516	CbGpPWpGaD
Maraviroc—Diarrhoea—Doxorubicin—stomach cancer	0.00015	0.000251	CcSEcCtD
Maraviroc—Rash—Epirubicin—stomach cancer	0.000149	0.00025	CcSEcCtD
Maraviroc—Dermatitis—Epirubicin—stomach cancer	0.000149	0.000249	CcSEcCtD
Maraviroc—Headache—Epirubicin—stomach cancer	0.000148	0.000248	CcSEcCtD
Maraviroc—CCR5—Disease—MAPK3—stomach cancer	0.000146	0.000502	CbGpPWpGaD
Maraviroc—Dizziness—Doxorubicin—stomach cancer	0.000145	0.000242	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PIK3CA—stomach cancer	0.000143	0.000491	CbGpPWpGaD
Maraviroc—CCR5—Disease—MYC—stomach cancer	0.000142	0.000488	CbGpPWpGaD
Maraviroc—Nausea—Epirubicin—stomach cancer	0.00014	0.000235	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ERBB2—stomach cancer	0.00014	0.000482	CbGpPWpGaD
Maraviroc—Vomiting—Doxorubicin—stomach cancer	0.000139	0.000233	CcSEcCtD
Maraviroc—CCR5—Disease—MAPK1—stomach cancer	0.000139	0.000478	CbGpPWpGaD
Maraviroc—CCR5—Disease—EGFR—stomach cancer	0.000139	0.000477	CbGpPWpGaD
Maraviroc—Rash—Doxorubicin—stomach cancer	0.000138	0.000231	CcSEcCtD
Maraviroc—Dermatitis—Doxorubicin—stomach cancer	0.000138	0.000231	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTP1—stomach cancer	0.000138	0.000475	CbGpPWpGaD
Maraviroc—Headache—Doxorubicin—stomach cancer	0.000137	0.000229	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	0.000136	0.000468	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL8—stomach cancer	0.000133	0.000457	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HRAS—stomach cancer	0.000132	0.000454	CbGpPWpGaD
Maraviroc—CCR5—Disease—KRAS—stomach cancer	0.000131	0.000451	CbGpPWpGaD
Maraviroc—Nausea—Doxorubicin—stomach cancer	0.00013	0.000218	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CDKN1B—stomach cancer	0.00013	0.000447	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—stomach cancer	0.000127	0.000436	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—stomach cancer	0.000126	0.000435	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	0.000125	0.00043	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCND1—stomach cancer	0.000124	0.000426	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JUN—stomach cancer	0.000123	0.000425	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3CA—stomach cancer	0.00012	0.000414	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP9—stomach cancer	0.00012	0.000414	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CDKN1A—stomach cancer	0.00012	0.000412	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACAD8—stomach cancer	0.000118	0.000408	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK8—stomach cancer	0.000117	0.000402	CbGpPWpGaD
Maraviroc—CCR5—Disease—HRAS—stomach cancer	0.000111	0.000383	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—stomach cancer	0.000108	0.000372	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT3—stomach cancer	0.000107	0.000368	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—stomach cancer	0.000107	0.000367	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GMPR2—stomach cancer	0.000106	0.000364	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK3—stomach cancer	0.000102	0.000351	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MYC—stomach cancer	9.93e-05	0.000342	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK1—stomach cancer	9.71e-05	0.000334	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EGFR—stomach cancer	9.71e-05	0.000334	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SUCLG1—stomach cancer	9.66e-05	0.000333	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—IDH3B—stomach cancer	9.66e-05	0.000333	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KRAS—stomach cancer	9.17e-05	0.000316	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NDUFS1—stomach cancer	8.98e-05	0.000309	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NDUFV1—stomach cancer	8.98e-05	0.000309	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CA—stomach cancer	8.43e-05	0.00029	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—stomach cancer	8.15e-05	0.000281	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PGLS—stomach cancer	8e-05	0.000276	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—BLVRB—stomach cancer	8e-05	0.000276	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HRAS—stomach cancer	7.8e-05	0.000268	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPAP2A—stomach cancer	7.63e-05	0.000263	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—stomach cancer	7.46e-05	0.000257	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FBP1—stomach cancer	6.8e-05	0.000234	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA1—stomach cancer	6.8e-05	0.000234	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CKB—stomach cancer	6.8e-05	0.000234	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NDUFA2—stomach cancer	6.8e-05	0.000234	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLIN2—stomach cancer	6.4e-05	0.00022	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA2—stomach cancer	6.22e-05	0.000214	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NT5E—stomach cancer	6.06e-05	0.000209	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PGAM1—stomach cancer	6.06e-05	0.000209	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH7A1—stomach cancer	5.79e-05	0.000199	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCE1—stomach cancer	5.79e-05	0.000199	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UMPS—stomach cancer	5.55e-05	0.000191	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PDHA1—stomach cancer	5.16e-05	0.000178	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ECHS1—stomach cancer	5.16e-05	0.000178	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TYMP—stomach cancer	4.85e-05	0.000167	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FADS1—stomach cancer	4.85e-05	0.000167	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SREBF2—stomach cancer	4.54e-05	0.000156	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—RORA—stomach cancer	4.49e-05	0.000154	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDOB—stomach cancer	4.2e-05	0.000145	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX5—stomach cancer	3.91e-05	0.000135	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DPYD—stomach cancer	3.84e-05	0.000132	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTT1—stomach cancer	3.4e-05	0.000117	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.36e-05	0.000116	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.27e-05	0.000113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO1—stomach cancer	3.19e-05	0.00011	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CD44—stomach cancer	2.83e-05	9.73e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.4e-05	8.27e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTP1—stomach cancer	2.36e-05	8.12e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—stomach cancer	2.32e-05	8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TYMS—stomach cancer	2.19e-05	7.54e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—stomach cancer	2.17e-05	7.46e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ERCC2—stomach cancer	2.04e-05	7.01e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—stomach cancer	1.91e-05	6.59e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAV1—stomach cancer	1.77e-05	6.08e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA1—stomach cancer	1.76e-05	6.07e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—stomach cancer	1.55e-05	5.34e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—stomach cancer	1.4e-05	4.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—stomach cancer	1.33e-05	4.6e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—stomach cancer	1.22e-05	4.2e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CA—stomach cancer	7.51e-06	2.59e-05	CbGpPWpGaD
